Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
ACS EST Air ; 1(4): 283-293, 2024 Apr 12.
Article in English | MEDLINE | ID: mdl-38633206

ABSTRACT

Global ground-level measurements of elements in ambient particulate matter (PM) can provide valuable information to understand the distribution of dust and trace elements, assess health impacts, and investigate emission sources. We use X-ray fluorescence spectroscopy to characterize the elemental composition of PM samples collected from 27 globally distributed sites in the Surface PARTiculate mAtter Network (SPARTAN) over 2019-2023. Consistent protocols are applied to collect all samples and analyze them at one central laboratory, which facilitates comparison across different sites. Multiple quality assurance measures are performed, including applying reference materials that resemble typical PM samples, acceptance testing, and routine quality control. Method detection limits and uncertainties are estimated. Concentrations of dust and trace element oxides (TEO) are determined from the elemental dataset. In addition to sites in arid regions, a moderately high mean dust concentration (6 µg/m3) in PM2.5 is also found in Dhaka (Bangladesh) along with a high average TEO level (6 µg/m3). High carcinogenic risk (>1 cancer case per 100000 adults) from airborne arsenic is observed in Dhaka (Bangladesh), Kanpur (India), and Hanoi (Vietnam). Industries of informal lead-acid battery and e-waste recycling as well as coal-fired brick kilns likely contribute to the elevated trace element concentrations found in Dhaka.

2.
J Air Waste Manag Assoc ; 73(11): 843-852, 2023 11.
Article in English | MEDLINE | ID: mdl-37768033

ABSTRACT

The Interagency Monitoring of PROtected Visual Environments (IMPROVE) network has collected airborne particulate matter (PM) samples at locations throughout the United States since 1988 and provided chemical speciation measurements on the samples using several techniques including X-ray fluorescence (XRF). New XRF instruments for measuring PM elemental content of IMPROVE samples were introduced in 2011. To evaluate the performance of these new instruments relative to the old instruments, archived sample from three IMPROVE monitoring sites were retrieved and analyzed on the new instruments. The agreement between the two instruments varied by element. Comparisons of the results were very good (slopes within 10% of unity) for most elements regularly measured well above the detection limits (sulfur, chlorine, potassium, titanium, vanadium, manganese, iron, copper, zinc, selenium, lead). Different particle compositions at the three sites highlighted different measurement interferences. High sea salt concentrations at the coastal site emphasized corrections applied in the old systems to light elements - sodium and magnesium - and resulted in poor agreement for these elements. Comparisons of the XRF measurements with collocated sulfate measurements by ion chromatography suggest that sulfur measurements from the new instruments are more precise but slight underestimates. Comparing elemental ratios to expected ratios for soil-derived PM demonstrate the new instruments are better at resolving the aluminum and silicon peaks.Implications: The presented work represents a comprehensive analysis of the method change enacted within the Interagency Monitoring of PROtected Visual Environments (IMPROVE) air monitoring network. This work describes the implications of the last change in elemental quantification methodology. The most important point for data users performing longitudinal analyses is that light elements (e.g., sodium - sulfur) were affected; the old instrumentation overestimated these elements while the current measurements are slightly underestimated. The authors recommend these results to be taken into consideration when interpreting sea salt and crustal sources of atmospheric dust.


Subject(s)
Air Pollutants , Air Pollution , United States , Air Pollutants/analysis , Air Pollution/analysis , Environmental Monitoring/methods , Particulate Matter/analysis , Sodium/analysis , Sulfur/analysis
3.
Atmos Environ (1994) ; 2232020 Feb 15.
Article in English | MEDLINE | ID: mdl-32095102

ABSTRACT

Black carbon (BC) is an important contributor to global particulate matter emissions. BC is associated with adverse health effects, and an important short-lived climate pollutant. Here, we describe a low cost method of analysis that utilizes images of PTFE filters taken with a digital camera to estimate BC content on filters. This method is compared with two existing optical methods for analyzing BC (Smokestain Reflectance and Hybrid Integrating Plate and Sphere System) as well as the standard chemical analysis method for determining elemental carbon (Thermal-Optical Reflectance). In comparisons of aerosol generated under controlled conditions (using an inverted diffusion flame burner to cover a range of mass loading and reflectance levels) (N=12) and in field samples collected from residential solid fuel combustion in China and India (N=50), the image-based method was found to correlate well (normalized RMSE <10% for all comparisons) with existing methods. A correlational analysis of field samples between the optical methods and Fourier-transform infrared spectroscopy indicated that the same functional groups were predominantly responsible for light attenuation in each optical method. This method offers reduced equipment cost, rapid analysis time, and is available at no cost, which may facilitate more measurement of BC where PM2.5 mass concentrations are already measured, especially in low income countries or other sampling efforts with limited resources.

4.
Adv Drug Deliv Rev ; 63(7): 518-31, 2011 Jun 19.
Article in English | MEDLINE | ID: mdl-21047543

ABSTRACT

Accelerator Mass Spectrometry is an established technology whose essentiality extends beyond simply a better detector for radiolabeled molecules. Attomole sensitivity reduces radioisotope exposures in clinical subjects to the point that no population need be excluded from clinical study. Insights in human physiochemistry are enabled by the quantitative recovery of simplified AMS processes that provide biological concentrations of all labeled metabolites and total compound related material at non-saturating levels. In this paper, we review some of the exploratory applications of AMS (14)C in toxicological, nutritional, and pharmacological research. This body of research addresses the human physiochemistry of important compounds in their own right, but also serves as examples of the analytical methods and clinical practices that are available for studying low dose physiochemistry of candidate therapeutic compounds, helping to broaden the knowledge base of AMS application in pharmaceutical research.


Subject(s)
Clinical Trials as Topic/methods , Drug Design , Mass Spectrometry/methods , Animals , Carbon Radioisotopes , Dose-Response Relationship, Drug , Drug-Related Side Effects and Adverse Reactions , Humans , Pharmaceutical Preparations/administration & dosage , Pharmaceutical Preparations/metabolism
5.
Bioanalysis ; 2(3): 455-68, 2010 Mar.
Article in English | MEDLINE | ID: mdl-21083255

ABSTRACT

Accelerator mass spectrometers have an energy acceleration and charge exchange between mass definition stages to destroy molecular isobars and allow single ion counting of long-lived isotopes such as (14)C (t½=5370 years.). 'Low' voltage accelerations to 200 kV allow laboratory-sized accelerator mass spectrometers instruments for bioanalytical quantitation of (14)C to 2-3% precision and accuracy in isolated biochemical fractions. After demonstrating this accuracy and precision for our new accelerator mass spectrometer, we discuss the critical aspects of maintaining quantitative accuracy from the defined biological fraction to the accelerator mass spectrometry quantitation. These aspects include sufficient sample mass for routine rapid sample preparation, isotope dilution to assure this mass, isolation of the carbon from other sample combustion gasses and use of high-efficiency biochemical separations. This review seeks to address a bioanalytical audience, who should know that high accuracy data of physiochemical processes within living human subjects are available, as long as a (14)C quantitation can be made indicative of the physiochemistry of interest.


Subject(s)
Mass Spectrometry/methods , Analytic Sample Preparation Methods , Carbon Radioisotopes/analysis , Carbon Radioisotopes/chemistry , Humans
6.
Bioanalysis ; 2(3): 441-54, 2010 Mar.
Article in English | MEDLINE | ID: mdl-21083254

ABSTRACT

Quantitative assessment of metabolites of drug candidates in early-phase clinical development presents an analytical challenge when methods, standards and assays are not yet available. Radioisotopic labeling, principally with radiocarbon ((14)C), is the preferred method for discovering and quantifying the absolute yields of metabolites in the absence of reference material or a priori knowledge of the human metabolism. However, the detection of (14)C is inefficient by decay counting methods and, as a result, high radiological human (14)C-doses had been needed to assure sensitive detection of metabolites over time. High radiological doses and the associated costs have been a major obstacle to the routine (and early) use of (14)C despite the recognized advantages of a (14)C-tracer for quantifying drug metabolism and disposition. Accelerator mass spectrometry eliminates this long-standing problem by reducing radioactivity levels while delivering matrix-independent quantitation to attomole levels of sensitivity in small samples or fractionated isolates. Accelerator mass spectrometry and trace (14)C-labeled drugs are now used to obtain early insights into the human metabolism of a drug candidate in ways that were not previously practical. With this article we describe some of our empirically based approaches for regualted bioanalysis and offer perspectives on current applications and opportunities for the future.


Subject(s)
Chemistry Techniques, Analytical/methods , Clinical Trials, Phase I as Topic/methods , Radioactive Tracers , Absorption , Animals , Chromatography, Liquid , Humans , Quality Control
SELECTION OF CITATIONS
SEARCH DETAIL
...